Drawing for PHARMFILM

USPTO serial 90257563

PHARMFILM

Reviewed by CopyMark Law Group

Reg. 6424386Status 700Renewal
Filing date
Status date
Registration date
Jul 20, 2021
Examiner
MCNAMARA, SHANA MARIE
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with PHARMFILM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*

Plus Government fees of $325

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Carrie Webb Olson

Carrie Webb Olson DAY PITNEY LLPOne Federal Street, 29th FloorBoston, MA 02110United States

Goods and services

ClassDescriptionStatusFirst use
005Films dissolvable in the mouth for the oral delivery of drugs, pharmaceuticals and dietary supplements to humans; Dissolvable polymer films as a base in preparations for oral, sublingual, buccal, or transmucosal delivery of pharmaceutically active ingredients; Drug delivery platform technology, namely, drug delivery agents consisting of compounds that facilitate, enhance or promote optimized delivery, dosing management and accuracy, enhanced solubility, enhanced permeability, or enhanced absorption of a wide range of pharmaceutical agents; pharmaceutical preparations, namely, oral, sublingual, buccal, or transmucosal delivery enhancement agents to facilitate, enhance, or promote optimized delivery, dosing management and accuracy, enhanced solubility, enhanced permeability or enhanced absorption of a variety of pharmaceutical agentsACTIVEDec 1, 2008

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 20, 2026REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jul 26, 2024EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Jul 26, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 26, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 26, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 26, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jul 26, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Aug 25, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 25, 2022EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Aug 25, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 25, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 20, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 4, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 4, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 14, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 26, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 26, 2021XAECEXAMINER'S AMENDMENT ENTERED—
Mar 26, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 26, 2021GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 26, 2021CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 15, 2021DOCKASSIGNED TO EXAMINER—
Dec 3, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 19, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance